Boston Trust Walden’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $63.1M | Sell |
151,891
-1,690
| -1% | -$626K | 0.48% | 71 |
|
|
2026
Q1 | $41.6M | Sell |
153,581
-1,745
| -1% | -$520K | 0.34% | 111 |
|
|
2025
Q4 | $51.3M | Sell |
155,326
-574
| -0.4% | -$195K | 0.39% | 98 |
|
|
2025
Q3 | $53.8M | Sell |
155,900
-48,057
| -24% | -$14.5M | 0.4% | 101 |
|
|
2025
Q2 | $63.6M | Sell |
203,957
-90,605
| -31% | -$34.6M | 0.45% | 79 |
|
|
2025
Q1 | $154M | Sell |
294,562
-1,501
| -0.5% | -$767K | 1.13% | 12 |
|
|
2024
Q4 | $150M | Buy |
296,063
+1,893
| +0.6% | +$1.08M | 1.05% | 13 |
|
|
2024
Q3 | $172M | Sell |
294,170
-2,550
| -0.9% | -$1.44M | 1.2% | 11 |
|
|
2024
Q2 | $151M | Sell |
296,720
-9,435
| -3% | -$4.62M | 1.12% | 11 |
|
|
2024
Q1 | $151M | Buy |
306,155
+1,276
| +0.4% | +$649K | 1.08% | 13 |
|
|
2023
Q4 | $161M | Buy |
304,879
+490
| +0.2% | +$261K | 1.21% | 13 |
|
|
2023
Q3 | $153M | Buy |
304,389
+1,132
| +0.4% | +$557K | 1.29% | 13 |
|
|
2023
Q2 | $146M | Buy |
303,257
+911
| +0.3% | +$445K | 1.2% | 12 |
|
|
2023
Q1 | $143M | Buy |
302,346
+23,758
| +9% | +$11.5M | 1.23% | 11 |
|
|
2022
Q4 | $148M | Sell |
278,588
-1,647
| -0.6% | -$872K | 1.3% | 7 |
|
|
2022
Q3 | $142M | Sell |
280,235
-8,621
| -3% | -$4.53M | 1.4% | 7 |
|
|
2022
Q2 | $148M | Buy |
288,856
+104
| +0% | +$52.2K | 1.4% | 7 |
|
|
2022
Q1 | $147M | Sell |
288,752
-794
| -0.3% | -$383K | 1.22% | 9 |
|
|
2021
Q4 | $145M | Buy |
289,546
+6,088
| +2% | +$2.76M | 1.17% | 10 |
|
|
2021
Q3 | $111M | Sell |
283,458
-4,224
| -1% | -$1.75M | 0.98% | 17 |
|
|
2021
Q2 | $115M | Buy |
287,682
+5,352
| +2% | +$2.13M | 1.02% | 13 |
|
|
2021
Q1 | $105M | Buy |
282,330
+5,922
| +2% | +$2.05M | 1.02% | 14 |
|
|
2020
Q4 | $96.9M | Sell |
276,408
-1,762
| -0.6% | -$591K | 1.03% | 15 |
|
|
2020
Q3 | $86.7M | Buy |
278,170
+235
| +0.1% | +$72.2K | 1.08% | 14 |
|
|
2020
Q2 | $82M | Sell |
277,935
-10,105
| -4% | -$2.9M | 1.11% | 13 |
|
|
2020
Q1 | $71.8M | Sell |
288,040
-46,140
| -14% | -$12.7M | 1.14% | 14 |
|
|
2019
Q4 | $98.2M | Buy |
334,180
+1,235
| +0.4% | +$323K | 1.14% | 15 |
|
|
2019
Q3 | $72.4M | Sell |
332,945
-384
| -0.1% | -$92.7K | 0.91% | 27 |
|
|
2019
Q2 | $81.3M | Buy |
333,329
+5,512
| +2% | +$1.33M | 1.06% | 22 |
|
|
2019
Q1 | $81.1M | Buy |
327,817
+9,186
| +3% | +$2.34M | 1.1% | 19 |
|
|
2018
Q4 | $79.4M | Sell |
318,631
-3,809
| -1% | -$1.01M | 1.26% | 14 |
|
|
2018
Q3 | $85.8M | Buy |
322,440
+110
| +0% | +$28.6K | 1.18% | 16 |
|
|
2018
Q2 | $79.1M | Buy |
322,330
+786
| +0.2% | +$189K | 1.16% | 16 |
|
|
2018
Q1 | $68.8M | Sell |
321,544
-1,540
| -0.5% | -$352K | 1.04% | 22 |
|
|
2017
Q4 | $71.2M | Buy |
323,084
+850
| +0.3% | +$180K | 1.04% | 20 |
|
|
2017
Q3 | $63.1M | Buy |
322,234
+3,353
| +1% | +$648K | 0.98% | 21 |
|
|
2017
Q2 | $59.1M | Buy |
318,881
+12,520
| +4% | +$2.2M | 0.95% | 26 |
|
|
2017
Q1 | $50.2M | Buy |
306,361
+3,225
| +1% | +$528K | 0.78% | 31 |
|
|
2016
Q4 | $48.5M | Buy |
303,136
+5,985
| +2% | +$894K | 0.76% | 33 |
|
|
2016
Q3 | $41.6M | Buy |
297,151
+75,902
| +34% | +$10.6M | 0.69% | 39 |
|
|
2016
Q2 | $31.2M | Buy |
221,249
+49,531
| +29% | +$6.6M | 0.53% | 61 |
|
|
2016
Q1 | $22.1M | Buy |
+171,718
| New | +$20.3M | 0.39% | 100 |
|
Other funds holding UNH
PAM
ECSS
Boston Trust Walden's UNH Position: Q2 2026 in Review
Boston Trust Walden reduced its UnitedHealth (UNH) stake by 1.1% in Q2 2026, selling an estimated $626K and leaving 151,891 shares worth $63.1M. The position accounts for 0.48% of the portfolio, ranked #71.
Boston Trust Walden first reported a position in UNH in Q1 2016 and has held it in 42 quarters since. The position peaked at $172M in Q3 2024. 1,395 funds tracked by Wall St. Rank hold UNH as of Q2 2026.
- Boston Trust Walden held 151,891 shares of UnitedHealth worth $63.1M as of Q2 2026.
- Boston Trust Walden sold 1,690 UnitedHealth shares in Q2 2026, an estimated $626K.
- UnitedHealth made up 0.48% of Boston Trust Walden's portfolio in Q2 2026, its #71 holding.
- Boston Trust Walden first reported a position in UnitedHealth in Q1 2016 and has held it in 42 quarters since.
- Boston Trust Walden's UnitedHealth position peaked at $172M in Q3 2024.
- 1,395 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.
Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.